New ultrasound technique could spot cancer in lymph nodes without a needle
NCT ID NCT07155954
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests a new type of ultrasound called super-resolution ultrasound (SRUS) to see if it can better tell the difference between benign (non-cancerous) and malignant (cancerous) swollen lymph nodes. About 779 adults with abnormal lymph nodes will receive an injection of ultrasound contrast agent, and the movement of tiny bubbles will be tracked to create a detailed map of blood vessels. The goal is to improve diagnostic accuracy and potentially reduce the need for invasive biopsies.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Ultrasound contrast agent (Sonovue or Sonazoid)
- What this could lead to
- If successful, this could give doctors a more accurate, non-invasive way to tell if swollen lymph nodes are cancerous or not, reducing unnecessary biopsies.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment. The technique may not prove more accurate than current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHADENOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, 100049, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can engineered immune cells tackle brain lymphoma?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a targeted pill boost Chemotherapy's punch against lymphoma?